Given the clear clinical and biochemical evidence pointing towards HIF2α driving polycythemia and PPGL, the balance of HIF-dependent or HIF-independent pVHL roles in RCC instead becomes the focus. The gene discussed is EPAS1; the disease is polycythemia.